Precision IVF, at-home IVF, and low-cost IVF: where the field is heading

Since the first IVF birth in 1978, assisted reproduction has helped millions of people have children. Yet IVF remains expensive, success is not guaranteed, and access is uneven. The World Health Organization notes that high costs are a major barrier to fertility care worldwide.

The access problem

In the United States, most patients pay out of pocket for fertility care because insurance coverage is limited, according to KFF. Outcomes also depend strongly on age; MedlinePlus notes that live birth rates depend on factors such as the mother's age.

Technologies that aim to help

• Electronic witnessing: barcode or chip systems that track eggs, sperm, and embryos to prevent mix-ups.
• Automated cryostorage: systems that monitor frozen eggs and embryos.
• At-home monitoring: tools that may reduce the number of clinic visits.
• Artificial intelligence: software being studied to help with embryo selection and treatment planning.

Promise versus evidence

Many of these tools can improve safety and efficiency, but improved efficiency does not automatically mean more babies. For example, a Cochrane review found insufficient evidence that time-lapse embryo monitoring improves live birth rates. Age and human biology still set limits that technology cannot yet overcome. "Precision," "at-home," and "low-cost" IVF are goals, and patients should ask for evidence before paying for new tools.